Close Window

Digital Look Email A Friend

Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP)

Published by Sharecast on 19th December 2025

URL: http://www.digitallook.com/dl/news/story/35574709/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.